salmeterol xinafoate has been researched along with Aging in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernabei, R; Corbo, GM; Pasciuto, G; Valente, S | 1 |
| Darken, PF | 1 |
1 review(s) available for salmeterol xinafoate and Aging
| Article | Year |
|---|---|
Do we need different treatments for very elderly COPD patients?
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Aging; Albuterol; Bronchodilator Agents; Glucocorticoids; Humans; Medication Adherence; Polypharmacy; Pulmonary Disease, Chronic Obstructive; Respiratory Muscles; Respiratory Physiological Phenomena; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide | 2010 |
1 other study(ies) available for salmeterol xinafoate and Aging
| Article | Year |
|---|---|
Evaluating assumptions for least squares analysis using the general linear model: a guide for the pharmaceutical industry statistician.
Topics: Aging; Albuterol; Androstadienes; Bronchodilator Agents; Data Interpretation, Statistical; Drug Industry; Fluticasone; Forced Expiratory Volume; Humans; Least-Squares Analysis; Linear Models; Pulmonary Disease, Chronic Obstructive; Research Design; Salmeterol Xinafoate; United States | 2004 |